US Stock MarketDetailed Quotes

IDYA IDEAYA Biosciences

Watchlist
  • 25.610
  • +0.820+3.31%
Close Dec 20 16:00 ET
  • 25.610
  • 0.0000.00%
Post 20:01 ET
2.21BMarket Cap-10.99P/E (TTM)

IDEAYA Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.17%-49.23M
1.73%-32.88M
-57.36%-43.81M
-32.18%-115.22M
-1.62%-23.75M
-24.86%-30.17M
-67.37%-33.46M
-41.71%-27.84M
-56.29%-87.18M
-40.30%-23.37M
Net income from continuing operations
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-17.87%-58.66M
-32.88%-24.2M
Depreciation and amortization
-1.36%1.01M
9.92%1.1M
12.71%1.08M
14.03%4.01M
11.06%1.02M
10.92%1.03M
16.05%998K
18.81%960K
15.93%3.52M
17.60%922K
Change In working capital
58.56%-2.28M
280.26%15.7M
26.75%-5.32M
69.26%-13.21M
526.04%8.26M
81.45%-5.5M
-333.50%-8.71M
22.69%-7.26M
-124.73%-42.97M
-10.05%-1.94M
-Change in receivables
99.71%-19K
-95.45%14K
101.17%3K
-78.36%193K
106.45%6.69M
-106.99%-6.54M
-24.69%308K
-163.30%-257K
15.25%892K
3,909.41%3.24M
-Change in prepaid assets
-178.69%-934K
90.44%-371K
-328.19%-3.13M
3.49%-2.05M
55.50%-724K
369.16%1.19M
-760.53%-3.88M
243.25%1.37M
-1,021.16%-2.12M
-889.81%-1.63M
-Change in payables and accrued expense
-160.87%-1.04M
1,438.23%16.59M
-300.46%-1.73M
-33.65%4.27M
486.94%4.23M
144.65%1.72M
-130.91%-1.24M
-142.97%-431K
19.67%6.44M
53.52%720K
-Change in other current liabilities
41.05%-280K
-17.21%-538K
-3.10%-465K
-10.18%-1.87M
-10.18%-487K
-10.21%-475K
-10.07%-459K
-10.27%-451K
-10.18%-1.7M
-10.22%-442K
-Change in other working capital
----
----
----
70.41%-13.75M
62.41%-1.44M
94.76%-1.38M
38.21%-3.44M
30.55%-7.5M
-97.44%-46.48M
-96.21%-3.83M
Cash from discontinued investing activities
Operating cash flow
-63.17%-49.23M
1.73%-32.88M
-57.36%-43.81M
-32.18%-115.22M
-1.62%-23.75M
-24.86%-30.17M
-67.37%-33.46M
-41.71%-27.84M
-56.29%-87.18M
-40.30%-23.37M
Investing cash flow
Cash flow from continuing investing activities
-139.02%-20.04M
156.48%68.56M
-1,604.91%-353.97M
-374.36%-158.46M
-989.36%-111.94M
374.83%51.35M
-1,011.54%-121.38M
232.43%23.52M
52.05%-33.4M
-2,388.14%-10.28M
Net PPE purchase and sale
24.21%-457K
-10.07%-973K
-2,981.40%-1.33M
31.22%-2.37M
---838K
45.23%-603K
54.46%-884K
89.28%-43K
-30.22%-3.44M
--0
Net investment purchase and sale
-137.69%-19.58M
157.70%69.53M
-1,596.55%-352.65M
-420.97%-156.09M
-981.21%-111.11M
395.47%51.95M
-889.78%-120.5M
235.74%23.56M
55.30%-29.96M
-5,452.08%-10.28M
Cash from discontinued investing activities
Investing cash flow
-139.02%-20.04M
156.48%68.56M
-1,604.91%-353.97M
-374.36%-158.46M
-989.36%-111.94M
374.83%51.35M
-1,011.54%-121.38M
232.43%23.52M
52.05%-33.4M
-2,388.14%-10.28M
Financing cash flow
Cash flow from continuing financing activities
929.33%286.5M
-79.49%39.18M
11,831.34%349.11M
273.30%362.72M
43,385.80%140.89M
-70.91%27.83M
38,813.03%191.06M
348.09%2.93M
-33.20%97.17M
-52.91%324K
Net common stock issuance
957.25%274.66M
-76.39%36.32M
13,323.83%343.65M
226.20%309.76M
24,937.82%127.42M
-72.81%25.98M
233,139.39%153.81M
28,544.44%2.56M
-33.71%94.96M
-2,130.43%-513K
Net preferred stock issuance
----
----
----
--42.18M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
538.33%11.84M
-92.32%2.86M
1,392.08%5.46M
388.97%10.77M
-3,529.63%-28.71M
1,161.90%1.86M
6,588.87%37.26M
-44.71%366K
0.09%2.2M
17.72%837K
Cash from discontinued financing activities
Financing cash flow
929.33%286.5M
-79.49%39.18M
11,831.34%349.11M
273.30%362.72M
43,385.80%140.89M
-70.91%27.83M
38,813.03%191.06M
348.09%2.93M
-33.20%97.17M
-52.91%324K
Net cash flow
Beginning cash position
77.63%183.96M
62.01%109.1M
129.53%157.78M
-25.41%68.74M
49.49%152.57M
110.45%103.57M
21.56%67.34M
-25.41%68.74M
27.74%92.15M
-5.96%102.06M
Current changes in cash
343.27%217.23M
106.66%74.86M
-3,389.10%-48.67M
480.27%89.04M
115.61%5.2M
-7.27%49.01M
685.64%36.22M
96.20%-1.4M
-217.02%-23.41M
-103.41%-33.32M
End cash Position
162.95%401.19M
77.63%183.96M
62.01%109.1M
129.53%157.78M
129.53%157.78M
49.49%152.57M
110.45%103.57M
21.56%67.34M
-25.41%68.74M
-25.41%68.74M
Free cash flow
-61.45%-49.69M
1.42%-33.86M
-61.87%-45.14M
-29.77%-117.59M
-5.20%-24.59M
-21.81%-30.78M
-56.59%-34.34M
-39.09%-27.89M
-55.11%-90.62M
-35.38%-23.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.17%-49.23M1.73%-32.88M-57.36%-43.81M-32.18%-115.22M-1.62%-23.75M-24.86%-30.17M-67.37%-33.46M-41.71%-27.84M-56.29%-87.18M-40.30%-23.37M
Net income from continuing operations -88.85%-51.82M-88.97%-52.77M-67.39%-39.57M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-68.70%-23.64M-17.87%-58.66M-32.88%-24.2M
Depreciation and amortization -1.36%1.01M9.92%1.1M12.71%1.08M14.03%4.01M11.06%1.02M10.92%1.03M16.05%998K18.81%960K15.93%3.52M17.60%922K
Change In working capital 58.56%-2.28M280.26%15.7M26.75%-5.32M69.26%-13.21M526.04%8.26M81.45%-5.5M-333.50%-8.71M22.69%-7.26M-124.73%-42.97M-10.05%-1.94M
-Change in receivables 99.71%-19K-95.45%14K101.17%3K-78.36%193K106.45%6.69M-106.99%-6.54M-24.69%308K-163.30%-257K15.25%892K3,909.41%3.24M
-Change in prepaid assets -178.69%-934K90.44%-371K-328.19%-3.13M3.49%-2.05M55.50%-724K369.16%1.19M-760.53%-3.88M243.25%1.37M-1,021.16%-2.12M-889.81%-1.63M
-Change in payables and accrued expense -160.87%-1.04M1,438.23%16.59M-300.46%-1.73M-33.65%4.27M486.94%4.23M144.65%1.72M-130.91%-1.24M-142.97%-431K19.67%6.44M53.52%720K
-Change in other current liabilities 41.05%-280K-17.21%-538K-3.10%-465K-10.18%-1.87M-10.18%-487K-10.21%-475K-10.07%-459K-10.27%-451K-10.18%-1.7M-10.22%-442K
-Change in other working capital ------------70.41%-13.75M62.41%-1.44M94.76%-1.38M38.21%-3.44M30.55%-7.5M-97.44%-46.48M-96.21%-3.83M
Cash from discontinued investing activities
Operating cash flow -63.17%-49.23M1.73%-32.88M-57.36%-43.81M-32.18%-115.22M-1.62%-23.75M-24.86%-30.17M-67.37%-33.46M-41.71%-27.84M-56.29%-87.18M-40.30%-23.37M
Investing cash flow
Cash flow from continuing investing activities -139.02%-20.04M156.48%68.56M-1,604.91%-353.97M-374.36%-158.46M-989.36%-111.94M374.83%51.35M-1,011.54%-121.38M232.43%23.52M52.05%-33.4M-2,388.14%-10.28M
Net PPE purchase and sale 24.21%-457K-10.07%-973K-2,981.40%-1.33M31.22%-2.37M---838K45.23%-603K54.46%-884K89.28%-43K-30.22%-3.44M--0
Net investment purchase and sale -137.69%-19.58M157.70%69.53M-1,596.55%-352.65M-420.97%-156.09M-981.21%-111.11M395.47%51.95M-889.78%-120.5M235.74%23.56M55.30%-29.96M-5,452.08%-10.28M
Cash from discontinued investing activities
Investing cash flow -139.02%-20.04M156.48%68.56M-1,604.91%-353.97M-374.36%-158.46M-989.36%-111.94M374.83%51.35M-1,011.54%-121.38M232.43%23.52M52.05%-33.4M-2,388.14%-10.28M
Financing cash flow
Cash flow from continuing financing activities 929.33%286.5M-79.49%39.18M11,831.34%349.11M273.30%362.72M43,385.80%140.89M-70.91%27.83M38,813.03%191.06M348.09%2.93M-33.20%97.17M-52.91%324K
Net common stock issuance 957.25%274.66M-76.39%36.32M13,323.83%343.65M226.20%309.76M24,937.82%127.42M-72.81%25.98M233,139.39%153.81M28,544.44%2.56M-33.71%94.96M-2,130.43%-513K
Net preferred stock issuance --------------42.18M------------------0----
Proceeds from stock option exercised by employees 538.33%11.84M-92.32%2.86M1,392.08%5.46M388.97%10.77M-3,529.63%-28.71M1,161.90%1.86M6,588.87%37.26M-44.71%366K0.09%2.2M17.72%837K
Cash from discontinued financing activities
Financing cash flow 929.33%286.5M-79.49%39.18M11,831.34%349.11M273.30%362.72M43,385.80%140.89M-70.91%27.83M38,813.03%191.06M348.09%2.93M-33.20%97.17M-52.91%324K
Net cash flow
Beginning cash position 77.63%183.96M62.01%109.1M129.53%157.78M-25.41%68.74M49.49%152.57M110.45%103.57M21.56%67.34M-25.41%68.74M27.74%92.15M-5.96%102.06M
Current changes in cash 343.27%217.23M106.66%74.86M-3,389.10%-48.67M480.27%89.04M115.61%5.2M-7.27%49.01M685.64%36.22M96.20%-1.4M-217.02%-23.41M-103.41%-33.32M
End cash Position 162.95%401.19M77.63%183.96M62.01%109.1M129.53%157.78M129.53%157.78M49.49%152.57M110.45%103.57M21.56%67.34M-25.41%68.74M-25.41%68.74M
Free cash flow -61.45%-49.69M1.42%-33.86M-61.87%-45.14M-29.77%-117.59M-5.20%-24.59M-21.81%-30.78M-56.59%-34.34M-39.09%-27.89M-55.11%-90.62M-35.38%-23.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.